#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cryoglobulinaemia Oesophageal squamous cell carcinoma stage II Thrombocytopenia Marfan's syndrome Follicle centre lymphoma follicular grade I II – III refractory Hereditary ataxia Metastases to peritoneum Obesity Pulmonary fibrosis Hyperinsulinaemic hypoglycaemia Ventricular fibrillation Extranodal marginal zone B-cell lymphoma (MALT type) KBG syndrome PIK3CA-activated mutation Chronic myeloid leukaemia (in remission) More trials…

    Learn about Rare Diseases

    Lymphangioma Hepatic angiosarcoma – Life with Disease Waldenstrom’s macroglobulinaemia – Life with Disease Malignant fibrous histiocytoma – Trials in Disease Basal cell naevus syndrome – Trials in Disease Mucous membrane pemphigoid – Treatment Haemophilia B without inhibitors – Diagnostics Haemophilia B without inhibitors – Trials in Disease Glycogen storage disease type II – Life with Disease Alveolar rhabdomyosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    2,4 DICHLOROBENZYL ALCOHOL Azenosertib Air, Medicinal Moxifloxacin Isis 696844 Codeine Phosphate Hemihydrate Imipenem Gsk6097608 Camlipixant NVG-2089 PHENTOLAMINE MESILATE Ceftazidime Pentahydrate Tebentafusp YOHIMBINE HYDROCHLORIDE Sodium Valproate Dextromethadone Hydrochloride Ponesimod Midazolam Hydrochloride Oxybutynin Ro7269162 More therapies…

    Learn about Your Condition

    Coronary artery bypass Pyoderma gangrenosum Castleman's disease Spinal cord injury cervical Ligament sprain Pertussis Strongyloidiasis Lymphocytic lymphoma Premature baby Small intestine carcinoma Gestational diabetes Paraganglion neoplasm Hydrocephalus Progressive multiple sclerosis Senile dementia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Safety and Effectiveness of Warfarin for Patients with Atrial Fibrillation Undergoing Dialysis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Haemodialysis
    • Peritoneal dialysis
    • Atrial fibrillation
    Investigated Drugs:
    • Warfarin Sodium
    Denmark

  • Study on Imlifidase and Drug Combination for Kidney Transplant in Highly Sensitized Children

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Kidney transplant rejection
    Investigated Drugs:
    • Anti-Human T-Lymphocyte Immunoglobulin From Rabbits
    • Immunglobulin
    • Imlifidase
    Finland France Spain Sweden

  • Study on Remifentanil and Sodium Chloride for Safe Intubation in Stable Newborns

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Endotracheal intubation
    Investigated Drugs:
    • Remifentanil
    • Sodium Chloride
    Belgium

  • Study on Walking Rehabilitation for Hip or Knee Osteoarthritis Using Ketoprofen and Drug Combination for Patients with Osteoarthritis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Diclofenac Epolamine
    • Niflumic Acid
    • Ibuprofen
    France

  • Study on Blood Pressure Management with Amiloride Hydrochloride, Indapamide, and Furosemide for Patients with Uncontrolled Hypertension and Chronic Kidney Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypertension
    • Chronic kidney disease
    Investigated Drugs:
    • Amiloride Hydrochloride
    • Furosemide
    • Hydrochlorothiazide
    France

  • Study on Zoledronic Acid Following Denosumab for Osteoporosis Patients

    Recruiting

    3 1 1
    Investigated Drugs:
    • Zoledronic Acid
    Denmark
Previous Page
1 … 576 577 578 579 580 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!